5,197
Views
5
CrossRef citations to date
0
Altmetric
Articles

Professional education to reduce provider stigma toward harm reduction and pharmacotherapy

ORCID Icon, , ORCID Icon, , &
Pages 576-586 | Received 09 Dec 2020, Accepted 20 May 2021, Published online: 08 Jul 2021

References

  • Allen, B., & Harocopos, A. (2016). Non-prescribed buprenorphine in New York City: Motivations for use, practices of diversion, and experiences of stigma. Journal of Substance Abuse Treatment, 70, 81–86. https://doi.org/10.1016/j.jsat.2016.08.002
  • Aspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Velzen, E. V., Palmateer, N., Doyle, J., Hellard, M., & Hutchinson, S. J. (2014). Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol, 43(1), 235–248. https://doi.org/10.1093/ije/dyt243
  • Bao, Y.-P., Liu, Z.-M., Epstein, D. H., Du, C., Shi, J., & Lu, L. (2009). A meta-analysis of retention in methadone maintenance by dose and dosing strategy. The American Journal of Drug and Alcohol Abuse, 35(1), 28–33. https://doi.org/10.1080/00952990802342899
  • Bland, E., Oppenheimer, L. W., Oppenheimer, L., Brisson-Carroll, G., Morel, C., Holmes, P., & Gruslin, A. (2001). Influence of an educational program on medical students' attitudes to substance use disorders in pregnancy. The American Journal of Drug and Alcohol Abuse, 27(3), 483–490. https://doi.org/10.1081/ADA-100104513
  • Brunson, J. C. (2020). ggalluvial: layered grammar for alluvial plots. Journal of Open Source Software, 5(49), 2017. https://doi.org/10.21105/joss.02017
  • Chaar, B. B., Wang, H., Day, C. A., Hanrahan, J. R., Winstock, A. R., & Fois, R. (2013). Factors influencing pharmacy services in opioid substitution treatment. Drug and Alcohol Review, 32(4), 426–434. https://doi.org/10.1111/dar.12032
  • Couto e Cruz, C., Salom, C. L., Dietze, P., Lenton, S., Burns, L., & Alati, R. (2018). Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing. Drug Alcohol Depend, 190, 188–194. https://doi.org/10.1016/j.drugalcdep.2018.06.009
  • Crapanzano, K., Vath, R. J., & Fisher, D. (2014). Reducing stigma towards substance users through an educational intervention: Harder than it looks. Academic Psychiatry, 38(4), 420–425. https://doi.org/10.1007/s40596-014-0067-1
  • Crawford, N. D., Amesty, S., Rivera, A. V., Harripersaud, K., Turner, A., & Fuller, C. M. (2014). Community impact of pharmacy-randomized intervention to improve access to syringes and services for injection drug users. Health Education & Behavior, 41(4), 397–405. https://doi.org/10.1177/1090198114529131
  • Davidson, P. J., Lozada, R., Rosen, P. C., Macias, A., Gallardo, M., & Pollini, R. A. (2012). Negotiating access: Social barriers to purchasing syringes at pharmacies in Tijuana, Mexico. International Journal of Drug Policy, 23(4), 286–294. https://doi.org/10.1016/j.drugpo.2012.05.001
  • Doe-Simkins, M., Quinn, E., Xuan, Z., Sorensen-Alawad, A., Hackman, H., Ozonoff, A., & Walley, A. Y. (2014). Overdose rescues by trained and untrained participants an change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health, 14(1), 297. https://doi.org/10.1186/1471-2458-14-297
  • Friedmann, P. D., Wilson, D., Knudsen, H. K., Ducharme, L. J., Welsh, W. N., Frisman, L., Knight, K., Lin, H.-J., James, A., Albizu-Garcia, C. E., Pankow, J., Hall, E. A., Urbine, T. F., Abdel-Salam, S., Duvall, J. L., & Vocci, F. J. (2015). Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections. Journal of Substance Abuse Treatment, 50, 50–58. https://doi.org/10.1016/j.jsat.2014.10.001
  • Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. Simon & Schuster.
  • Harris, J., & McElrath, K. (2012). Methadone as social control: Institutionalized stigma and the prospect of recovery. Qualitative Health Research, 22(6), 810–824. https://doi.org/10.1177/1049732311432718
  • Hatcher, A. E., Mendoza, S., & Hansen, H. (2018). At the expense of a life: Race, class, and the meaning of buprenorphine in pharmaceuticalized "care." Substance Use & Misuse, 53(2), 301–310. https://doi.org/10.1080/10826084.2017.1385633
  • Hatzenbuehler, M. L., Phelan, J. C., & Link, B. G. (2013). Stigma as a Fundamental Cause of Population Health Inequalities. Am J Public Health, 103(5), 813–821. https://doi.org/10.2105/AJPH.2012.301069
  • Kakko, J., Svanborg, K. D., Kreek, M. J., & Heilig, M. (2003). 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial. The Lancet, 361(9358), 662–668. https://doi.org/10.1016/S0140-6736(03)12600-1
  • Knudsen, H. K., Ducharme, L. J., Roman, P. M., & Link, T. (2005). Buprenorphine diffusion: The attitudes of substance abuse treatment counselors. Journal of Substance Abuse Treatment, 29(2), 95–106. https://doi.org/10.1016/j.jsat.2005.05.002
  • Livingston, J. D., Adams, E., Jordan, M., MacMillan, Z., & Hering, R. (2018). Primary care physicians' views about prescribing methadone to treat opioid use disorder. Substance Use & Misuse, 53(2), 344–353. https://doi.org/10.1080/10826084.2017.1325376
  • Lloyd, C. (2013). The stigmatization of problem drug users: A narrative literature review. Drugs Education Prevention Policy, 20(2), 85–95. https://doi.org/10.3109/09687637.2012.743506
  • MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., Degenhardt, L., & Hickman, M. (2012). Opiate substitution treatmentand HIV transmission in people who inject drugs: a systematic review and meta-analysis. BMJ, 345, e5945. https://doi.org/10.1136/bmj.e5945
  • Madden, E. F. (2019). Intervention stigma: How medication-assisted treatment marginalizes patients and providers. Social Science & Medicine, 232, 324–331. https://doi.org/10.1016/j.socscimed.2019.05.027
  • Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, 2, Art. No.: CD002207. https://doi.org/10.1002/14651858.CD002207.pub4
  • Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018). Stigma at every turn: Health services experiences among people who inject drugs. International Journal of Drug Policy, 57, 104–110. https://doi.org/10.1016/j.drugpo.2018.04.004
  • Peterson, J. A., Schwartz, R. P., & Mitchell, S. G. (2010). Why don't out-of-treatment individuals enter methadone treatment programs? International Journal on Drug Policy, 21(1), 36–42. https://doi.org/10.1016/j.drugpo.2008.07.004
  • R Core Team. (2020). R: A language and environment for statistical computing. https://www.R-project.org/
  • Ramirez-Cacho, W. A., Strickland, L., Beraun, C., Meng, C., & Rayburn, W. F. (2007). Medical students' attitudes toward pregnant women with substance use disorders. American Journal of Obstetrics and Gynecology, 196(1), 86.e1–86.e5. https://doi.org/10.1016/j.ajog.2006.06.092
  • Rieckmann, T. R., Abraham, A. J., Kovas, A. E., McFarland, B. H., & Roman, P. M. (2014). Impact of research network participation on the adoption of buprenorphine for substance abuse treatment. Addictive Behaviors, 39(5), 889–896. https://doi.org/10.1016/j.addbeh.2014.01.016
  • Rieckmann, T., Daley, M., Fuller, B. E., Thomas, C. P., & McCarty, D. (2007). Client and counselor attitudes toward the use of medications for treatment of opioid dependence. Journal of Substance Abuse Treatment, 32(2), 207–215. https://doi.org/10.1016/j.jsat.2006.09.002
  • Rosenblatt, R. A., Andrilla, C. H. A., Catlin, M., & Larson, E. H. (2015). Geographic and specialty distribution of U.S. physicians trained to treat opioid use disorder. Annals of Family Medicine, 13(1), 23–26. https://doi.org/10.1370/afm.1735
  • RStudio Team. (2019). RStudio: Integrated development for R. RStudio, Inc. http://www.rstudio.com/
  • Sjoberg, D. D., Hannum, M., Whiting, K., Zabor, E. C. (2020). Gtsummary: Presentation-ready data summary and analytic result tables. https://CRAN.R-project.org/package=gtsummary
  • Smye, V., Browne, A. J., Varcoe, C., & Josewski, V. (2011). Harm reduction, methadone maintenance treatment and the root causes of health and social inequities: An intersectional lens in the Canadian context. Harm Reduction Journal, 8(1), 17. https://doi.org/10.1186/1477-7517-8-17
  • Soyka, M., Träder, A., Klotsche, J., et al. (2011). Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: Results from a nationally representative cohort study. Journal of Clinical Psychopharmacology, 31(5), 678–680. https://doi.org/10.1097/JCP.0b013e31822cd446
  • Sulzer, S. H., Feinstein, N. W., & Wendland, C. L. (2015). Assessing empathy development in medical education: A systematic review. Medical Education, 50(3), 300–210. https://doi.org/10.1111/medu.12806
  • Sulzer, S. H., Jackson, G., & Yang, A. (2016). Borderline personality disorder and the biomedical mismatch. In 50 years after deinstitutionalization: Mental illness in contemporary communities (Advances in Medical Sociology, Vol. 17) (pp. 263–290). Emerald Group Publishing Limited. https://doi.org/10.1108/S1057-629020160000017011
  • von Hippel, C., Brener, L., & Horwitz, R. (2018). Implicit and explicit internalized stigma: Relationship with risky behaviors, psychosocial functioning and healthcare access among people who inject drugs. Addictive Behaviors, 76, 305–311. https://doi.org/10.1016/j.addbeh.2017.08.036
  • Wakeman, S. E., & Rich, J. D. (2018). Barriers to medications for addiction treatment: How stigma kills. Substance Use & Misuse, 53(2), 330–333. https://doi.org/10.1080/10826084.2017.1363238
  • Walley, A. Y., Xuan, Z., Hackman, H. H., et al. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, f174. https://doi.org/10.1136/bmj.f174
  • Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., Kuhn, M., Pedersen, T., Miller, E., Bache, S., Müller, K., Ooms, J., Robinson, D., Seidel, D., Spinu, V., … Yutani, H., et al. (2019). Welcome to the tidyverse. Journal of Open Source Software, 4(43), 1686. https://doi.org/10.21105/joss.01686
  • Winograd, R. P., Davis, C. S., Niculete, M., Oliva, E., & Martielli, R. P. (2017). Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings. Substance Abuse, 38(2), 135–140. https://doi.org/10.1080/08897077.2017.1303424
  • Yang, L. H., Wong, L. Y., Grivel, M. M., & Hasin, D. S. (2017). Stigma and substance use disorders: An international phenomenon. Curr Opin Psychiatry, 30(5), 378–388. https://doi.org/10.1097/YCO.0000000000000351
  • Zeileis, A. (2004). Econometric computing with H.C. and HAC covariance matrix estimators. Journal of Statistical Software, 11(1), 1–17. https://doi.org/10.18637/jss.v011.i10
  • Zeileis, A., & Hothorn, T. (2002). Diagnostic checking in regression relationships. R News, 2(3), 7–10.